UBryan Liu

UMlawuli weSebe leHlabathi, iSibhedlele seSikhululo seeNqwelo-moya saseTianJin Cancer Hospital

Ilungu leKomiti yeMithetho yokuziphatha kwiSibhedlele seSikhululo seenqwelo-moya saseTianJin Cancer Hospital

Umsunguli weBioocus Medical Group kunye neZiko le-CGT

Unjingalwazi woLawulo loPhando lwezeSayensi kwiSikolo seSayensi yoBomi, iZiko loBugcisa laseBeijing

Inkokeli yeQela eliSebenzayo leKomiti yoBugcisa beCellular Immunotherapy kwi-China Association for the Promotion of Human Health Technology

Ubuchule kwi-chemotherapy, unyango olujoliswe kuyo, unyango lwe-CAR-T, kunye ne-immunotherapy ye-hematologic monicancies.

Amava amaninzi eklinikhi aneemeko zegazi ezinobungozi ezifana ne-refractory kunye ne-relapse leukemia, i-lymphoma, kunye ne-multiple myeloma, onobuchule bokulawula iimeko ezinzima nezinzima.

Iphumelele kakhulu ekunyangeni amatyala aphindaphindayo kusetyenziswa unyango lwe-immunotherapy lweseli kwizigulane zamazwe ngamazwe, nto leyo ebonisa impumelelo ephawulekayo kunyango.

Usebenza njengomcebisi we-immunotherapy kwiZibhedlele zase-Apollo eIndiya, ekhuthaza intsebenziswano kwezonyango phakathi kwemida

Ngaphezulu kweminyaka eli-10 yamava eklinikhi ekuxilongeni nasekunyangeni izifo ezintsonkothileyo zegazi.

Ndithathe inxaxheba kwiimeko ezingaphezu kwama-300 zonyango lwe-immunotherapy lweseli kwizigulane zamazwe ngamazwe, kuquka iimeko ze-leukemia ephindaphindayo, i-lymphoma, i-Neuroblastoma, i-multiple myeloma, i-MG, i-SLE, i-SSC, i-Thalassemia, i-SCD, i-TDT.

Ndizinikele kwi-immunotherapy yeseli kunye nonyango lwe-gene kangangeminyaka engamashumi amabini.

Ndifumene iziphumo ezibalulekileyo kunyango lwe-CAR-T, unyango lwe-TILs, unyango lwe-NK, kunye nonyango lwe-gene.

Yasekwa amaziko amane onyango lweCellular kunye neGene (amaziko eCGT) eBeijing naseTianjin.